| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |